Showing posts with label education. Show all posts
Showing posts with label education. Show all posts
Thursday 6 April 2023
DEVELOPMENT OF ANXIETY IN BIPOLAR DISORDER
there is an accurate 
research findings regarding the comorbidity of anxiety disorders in individuals with bipolar disorder (BD). Studies have shown that approximately half of individuals with BD will develop an anxiety disorder at some point in their lives, and about a third will have an anxiety disorder at any given time.
The presence of an anxiety disorder comorbidity in individuals with BD can have a negative impact on various aspects of their presentation and course of illness, including treatment response and outcome. Unfortunately, there is limited research available on the underlying causes and optimal management of this comorbidity.
However, it is important for clinicians to be aware of this potential comorbidity and to screen individuals with BD for anxiety disorders. Providing comprehensive and ongoing treatment for both conditions can help prevent the negative consequences of anxiety disorder comorbidity in individuals with BD. This may include a combination of medication and psychotherapy, tailored to the specific needs of the individual.
Sunday 1 February 2009
THE MANAGEMENT OF VARIZELLA ZOSTER VIRUS EXPOSURE AND INFECTION IN PREGNANCY AND NEW BORN PERIOD
GOOD DAY
1.Zoster immunoglobulin (ZIG) should be offered to pregnant, varicella-seronegative women with significant exposure to varicella-zoster virus (VZV) (chickenpox) infection.
2.Oral aciclovir prophylaxis should be considered for susceptible pregnant women exposed to VZV who did not receive ZIG or have risk factors for severe disease.
3.Intravenous aciclovir should be given to pregnant women who develop complicated varicella at any stage of pregnancy.
4.Counselling on the risk of congenital varicella syndrome is recommended for pregnant women who develop chickenpox.
5.ZIG should be given to a baby whose mother develops chickenpox up to 7 days before delivery or up to 28 days after delivery.
6.Intravenous aciclovir should be given to babies presenting unwell with chickenpox, whether or not they received ZIG.
7.Breastfeeding of babies infected with or exposed to VZV is encouraged.
8.A mother with chickenpox or zoster does not need to be isolated from her own baby.
9.If siblings at home have chickenpox, a newborn baby should be given ZIG if its mother is seronegative.
10.The newborn baby does not need to be isolated from its siblings with chickenpox, whether or not the baby was given ZIG.
11.After significant nursery exposure to VZV, ZIG should be given to seronegative babies and to all babies born before 28 weeks' gestation.
1.Zoster immunoglobulin (ZIG) should be offered to pregnant, varicella-seronegative women with significant exposure to varicella-zoster virus (VZV) (chickenpox) infection.
2.Oral aciclovir prophylaxis should be considered for susceptible pregnant women exposed to VZV who did not receive ZIG or have risk factors for severe disease.
3.Intravenous aciclovir should be given to pregnant women who develop complicated varicella at any stage of pregnancy.
4.Counselling on the risk of congenital varicella syndrome is recommended for pregnant women who develop chickenpox.
5.ZIG should be given to a baby whose mother develops chickenpox up to 7 days before delivery or up to 28 days after delivery.
6.Intravenous aciclovir should be given to babies presenting unwell with chickenpox, whether or not they received ZIG.
7.Breastfeeding of babies infected with or exposed to VZV is encouraged.
8.A mother with chickenpox or zoster does not need to be isolated from her own baby.
9.If siblings at home have chickenpox, a newborn baby should be given ZIG if its mother is seronegative.
10.The newborn baby does not need to be isolated from its siblings with chickenpox, whether or not the baby was given ZIG.
11.After significant nursery exposure to VZV, ZIG should be given to seronegative babies and to all babies born before 28 weeks' gestation.
Subscribe to:
Posts (Atom)
